Detalhe da pesquisa
1.
Case Report: Dostarlimab for treatment of aggressive cutaneous squamous cell carcinoma.
Front Med (Lausanne)
; 11: 1322210, 2024.
Artigo
Inglês
| MEDLINE | ID: mdl-38529116
2.
HLA inherence as a potential parameter in checkpoint inhibitor-associated autoimmune adverse event assessment.
Front Med (Lausanne)
; 10: 1288844, 2023.
Artigo
Inglês
| MEDLINE | ID: mdl-38259857